|
|
|
|
Director / VP Marketing Business Development Resume
|
| Desired Industry: Biotech |
SpiderID: 15295 |
| Desired Job Location: Milford, Massachusetts |
Date Posted: 9/4/2007 |
| Type of Position: Full-Time Permanent |
Availability Date: Now |
| Desired Wage: Neg. |
|
|
U.S. Work Authorization: Yes |
| Job Level: Management (Manager, Director) |
Willing to Travel: Yes, More Than 75% |
| Highest Degree Attained: Doctoral |
Willing to Relocate: Yes |
Objective:
Highly driven life sciences marketing and business development professional coupling a solid scientific biopharmaceutical and diagnostics background with extensive commercial operations experience. Responsible for creating over $50 million worth of new products and services, markets, strategic alliances, business-to-business deals, and licensing.
Looking for challening mangement position developing new products and/or services for the life sciences market.
Experience:
Vice President, Business Development, SeraCare Life Sciences, West Bridgewater and Milford, MA (Mar 2006 Aug 2007)
$55M global manufacturer and distributor to pharmaceutical and diagnostics companies (OTC: SRLSQ - delisted). Products include IVD controls, serlogical panels, bulk products used in bioprocess manufacturing and cell culture, and research and repository services for clinical trials. Company entered voluntary Chapter 11 eight days after being hired.
Managed the Commercial Operations for the Bioprocessing Division inclusive of: Commercial Development, Direct Sales and Customer Service, Marketing, and New Product Development
Full P&L responsibility of $15M distribution and manufacturing BioProcess division with $2M direct GS&A responsibility
Lead the development of the commercial strategy for post-bankruptcy emergence and growth
Lead closing of bulk sales contracts worth over $5M
Negotiated commercial contracts (supply agreements, distribution arrangements, etc.) worth ten million dollars
Consultant, Healthcare and Life Sciences Markets, Pegasystems, Cambridge, MA (Oct 2005 Mar 2006)
$120M Business Process Management (BPM) enterprise software company (NASDAQ:PEGA). Products include enterprise systems for leading global banks and financial institutions, investment houses, and insurance companies.
Developed market entry strategy and tactical plans for Life Sciences (Pharmaceutical, Biotechnology) markets, focussed on business processes for customer service and marketing, SOX compliance, and manufacturing
Global Commercial Director, Nucleic Acid Technologies SBU, Fisher Biosciences Group, Fisher Scientific International, Morris Plains, NJ (Jun 2004 Oct 2005)
$30M global strategic business unit, part of a $1.3B biochemical manufacturing and supply subdivision of a $7B global parent (NYSE: FSH). Products include large volume and bulk production of amidites, nucleosides, proteins, enzymes, reagents, OEM kit production, and custom chemical manufacturing services and products.
Full P&L responsibility of $30M manufacturing and direct sales business: Pierce Nucleic Acid Technology
$2M direct S&A responsibility
Grew revenue 20% year on year, during first six months while improving profitability
Restructured field sales and strategic marketing group to create market-facing organization
Executed global business deals (supply agreements, OEM contracts, etc.) worth over ten million dollars
Lead the launch of two new product lines (NuLight and NAT Synthesis System)
Sucessfully created and led rebranding strategy for the business unit (Fisher Biosciences Custom & OEM)
Vice President, Business Development of Signet Laboratories, Dedham, MA (Jun 2001 Nov 2003)
$3M private company developing new drug development technology (Magellan) for the non-image based screening of human tissues in therapeutic and diagnostics discovery, and a developer and manufacturer of antibodies, immunoassays, and clinical diagnostics for sepsis, cancer, and neurodegenerative disease
Created a $50 million business plan and strategy for a new drug discovery research service division
Closed licensing deals valued at collectively one-half million dollars in composite revenue
Created and implemented a strategic intellectual property program which evaluated current IP assets and produced strategies for the creation of new, high-value IP
Created a academic/research institution liaison program to increase corporate awareness and to provide first mover access advantage to new and novel technologies in development
Formed corporate strategic alliances with public companies and collaborative research programs with world-class research institutions to expedite new product development and increase brand awareness
Built Scientific Advisory Board comprised of world-class clinical and industry professionals
Created/managed multiple brands and trademarks for current and new products
Raised company profile as invited speaker and panelist at high-profile, international consortia (e.g. BIO 2003, Antibody Deal-Making Summit, Antibody Deal-Making and Partnering Conference)
Consultant & Director, Sales & Marketing, Xpogen, Inc, Newton, MA (Jan 2001 Jun 2001)
Venture-backed start-up created to commercialize a web-based platform (BioinformatiX Engine) for highly multi-dimensional functional genomics and proteomics data analysis and Internet collaboration, a fully integrated operating system for genomics analysis tool development (XOS), and a proprietary API for legacy tool integration (X-AD)
Devised marketing strategy and positioning for company; primary architect of business plan
Established sales and distribution partners
Raised $2M seed round financing
Director, Marketing & Product Management, CyberMedica, Inc, Marlboro, MA (Jan 2000 Jan 2001)
$20M venture-backed start-up created to commercialize web-enabled ASP tools for the healthcare and life sciences industries, including workflow and knowledge management solutions for IP management, IRB/IACUC proposal tracking, and clinical trials management
Created marketing and product management functions and processes for $1M priced platform products/services
Developed corporate strategy and product positioning; investors pitches, services and product specifications, launch plans, and strategic marketing materials
Validated product concepts and designs through market research and focus group studies
Senior Product Marketing Manager, Waters Corp, Milford, MA (Aug 1998 Sep 1999)
$3B public company (NYSE:WAT) and manufacturer of high performance liquid chromatography consumables and instruments, mass spectroscopy tools, and thermal analysis equipment for the analytical sciences markets
Managed a $6M life sciences product portfolio and cross-functional team responsible for creating product definitions and commercialization strategies for these products
Grew portfolio revenue 50% during tenure
Developed a pipeline containing several innovative new life sciences products
Managed Symmetry300 brand; launched new Symmetry300 products and extensions
Created an extensive market analysis of growth opportunities in emerging biotechnology and pharmaceutical markets and strategic plan to create a corporate position in the life sciences consumables market
Business Development Manager, Zymark Corp Hopkinton, MA (Nov 1997 Aug 1998)
$250M public company (NASDAQ:CALP) and manufacturer of laboratory automation, liquid handling, and lab-on-a-chip devices for the drug discovery market with an emphasis on high-throughput screening, and DNA/RNA analysis
Managed a $3M sales territory for laboratory automation and robotics products
Created strategic alliances for product development between Zymark and its pharmaceutical and biotechnology accounts in New Jersey, New York, the upper Midwest, and Eastern Canada.
Identified and launched new products as part of cross functional team comprised of marketing and product development personnel
Education:
--- Professional Education ---
Associate Scientist, Structural Biochemistry Program, National Cancer Institute, Frederick, MD (Oct 1993 Oct 1994)
Postdoctoral Fellow, Protein Engineering Dept., Genentech, Inc., South San Francisco, CA (Feb 1992 Oct 1993)
PhD Physical Biochemistry, Prof. M. Thomas Record Jr., University of Wisconsin at Madison (Apr 1986 Feb 1992)
BS Biochemistry, with honors (cum laude), University of Missouri at Columbia (Sep 1982 Apr 1986)
--- Recent Continuing Education ---
Advanced Business Development, BIO / Licensing Executives Society International (LESI) (2007)
Leadership Development Course, Fisher University (2004)
Intellectual Asset Management, Licensing Executives Society International (2002)
Fundamentals of Finance for the Technical Executive, MIT Sloan School of Management (2000)
Affiliations:
Association of Strategic Alliance Professionals
Licensing Executives Society International (LESI)
Biotechnology Industry Affiliate & Liaison, Association of University Technology Managers
MIT Venture Mentoring Service
MIT Enterprise Forum of Cambridge
Harvard Biotechnology Club
Former Chairman, American Association of Clinical Chemistry, Northeastern Section
Skills:
life science business development/sales/marketing
strategic alliance/relationship management
business and business planning strategy
marketing strategy and market development
competitive intelligence/assessment
intellectual property valuation and management
technology due diligence & asset evaluation
service and product portfolio management
Candidate Contact Information:
This candidate has chosen not to make contact information available on this page.
Click "Contact Candidate" to send this candidate a response. |
|
|
|
|
|